Rubius Therapeutics, Inc. - 10-Q filing on 2022-05-10

Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2022

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):



	March 31, 2022		December 31, 2021
Accrued employee compensation and benefits	$	2,152	$	7,451
Accrued external research and development expenses		3,065		2,713
Accrued manufacturing facility expenses		995		2,349
Accrued general and administrative expenses		710		889
Other		830		670
	$	7,752	$	14,072